Metabolomics-Based Clinical Efficacy of Compound Shenlu Granule, a Chinese Patent Medicine, in the Supportive Management of Aplastic Anemia Patients: A Randomized Controlled Pilot Trial

<div>Representative chromatogram of plasma samples of the SLG group derived from UPLC-Q-Exactive. (a) ESI positive mode and (b) ESI negative mode.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Metabolomics-Based Clinical Efficacy of Compound Shenlu Granule, a Chinese Patent Medicine, in the Supportive Management of Aplastic Anemia Patients: A Randomized Controlled Pilot Trial 

Figure 2 | Metabolomics-Based Clinical Efficacy of Compound Shenlu Granule, a Chinese Patent Medicine, in the Supportive Management of Aplastic Anemia Patients: A Randomized Controlled Pilot Trial 